Hyperfine (HYPR) to Release Quarterly Earnings on Tuesday

Hyperfine (NASDAQ:HYPR) is projected to issue its Q1 2025 quarterly earnings data after the market closes on Tuesday, May 13th. Analysts expect the company to announce earnings of ($0.12) per share and revenue of $2.82 million for the quarter. Hyperfine has set its FY 2025 guidance at EPS.

Hyperfine (NASDAQ:HYPR) last released its earnings results on Monday, March 17th. The company reported ($0.14) EPS for the quarter, topping the consensus estimate of ($0.16) by $0.02. Hyperfine had a negative return on equity of 57.54% and a negative net margin of 309.42%. The business had revenue of $2.32 million for the quarter, compared to the consensus estimate of $2.30 million. During the same period in the previous year, the company posted ($0.15) earnings per share. On average, analysts expect Hyperfine to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Hyperfine Trading Up 3.5%

Hyperfine stock opened at $0.74 on Monday. The business’s fifty day simple moving average is $0.77 and its two-hundred day simple moving average is $0.93. Hyperfine has a 12 month low of $0.58 and a 12 month high of $1.90. The company has a market capitalization of $57.93 million, a price-to-earnings ratio of -1.31 and a beta of 1.04.

Analyst Ratings Changes

Several research firms have recently weighed in on HYPR. Lake Street Capital began coverage on Hyperfine in a research note on Monday, March 24th. They issued a “buy” rating and a $1.50 price target for the company. B. Riley reduced their price objective on Hyperfine from $1.50 to $1.20 and set a “buy” rating for the company in a research report on Thursday, March 20th. Finally, Wells Fargo & Company upped their price target on Hyperfine from $1.10 to $1.29 and gave the stock an “equal weight” rating in a research report on Tuesday, March 18th.

About Hyperfine

Hyperfine, Inc, a medical device company, provides magnetic resonance imaging (MRI) products in the United States. The company offers Swoop Portable MR imaging system, which offers portable brain neuroimaging; and support and technical assistance services. It serves ICU, comprehensive, and primary stroke accredited facilities through direct sales and distributors.